MedTrace Logo

Characterization of Brain Metastases

NCT00184275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2014-03-07

No results posted yet for this study

Summary

The purpose is to characterize tumour biological markers in brain metastases tissue from patients with different primary tumour by using ex vivo techniques as high-resolution magic angle spinning MR spectroscopy and micro array.

Conditions

  • Neoplasm Metastasis
  • Lung Neoplasms
  • Breast Neoplasms
  • Melanoma

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Steinar Lundgren, MD PhD · Cancer Clinic, St.Olavs Hospital Trondheim University Hospital

  • Ingrid S Gribbestad, PhD · Norwegian University of Science and Technology, Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2007-05-31
Completion
2010-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184275 on ClinicalTrials.gov